Cantor Fitzgerald initiated coverage on Molina Healthcare with a new price target
$MOH
Medical Specialities
Health Care
Cantor Fitzgerald initiated coverage of Molina Healthcare with a rating of Overweight and set a new price target of $354.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/30/2024 | $405.00 | Outperform | Robert W. Baird |
| 3/28/2024 | $439.00 | Neutral → Underperform | BofA Securities |
| 3/6/2024 | $437.00 | Equal Weight | Barclays |
| 2/15/2024 | $367.00 → $420.00 | Underweight → Equal Weight | Wells Fargo |
| 6/20/2023 | $310.00 | Neutral | UBS |
| 4/21/2023 | $354.00 | Overweight | Cantor Fitzgerald |
| 12/13/2022 | $388.00 | Underperform → Neutral | BofA Securities |
| 10/3/2022 | $360.00 | Overweight | JP Morgan |
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
Robert W. Baird initiated coverage of Molina Healthcare with a rating of Outperform and set a new price target of $405.00
BofA Securities downgraded Molina Healthcare from Neutral to Underperform and set a new price target of $439.00
Barclays initiated coverage of Molina Healthcare with a rating of Equal Weight and set a new price target of $437.00
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
Cantor Fitzgerald analyst Sarah James reiterates Molina Healthcare (NYSE:MOH) with a Overweight and maintains $406 price target.
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.250% per annum. Interest on the Notes is payable semi-annually in arrears on January 15 and July 15 of each year, commencing July 15, 2025, and accrues from N
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $750 million aggregate principal amount of its 6.250% senior notes due 2033 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 18, 2024 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any of the C
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $500 million aggregate principal amount of senior notes due 2033 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will sell the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Company's sub
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,694 $ 8,240 $ 28,644 $ 24,167 Total Revenue $ 10,340 $ 8,548 $ 30,151
Molina Healthcare, Inc. (NYSE:MOH) ("Molina" or the "Company") today announced it will issue its earnings release for the third quarter ending September 30, 2024, after the market closes on Wednesday, October 23, 2024, and will host a conference call and webcast to discuss the earnings release on Thursday, October 24, 2024, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 7014206. A telephonic replay of the conference call will be available through Thursday, October 31, 2024, by dialing (877) 344-7529 and entering the confirmation number, 5232318. A live broadcast of Molina Healthcare's conference call will be avai
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2024 2023 2024 2023 (In millions, except per-share results) Premium Revenue $ 9,446 $ 8,042 $ 18,950